Study S000165

A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HRS-7535 Tablets in Subjects With Overweight or Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06904105
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 556
Start: 2025-04-10
Primary completion: 2026-04-17
Lead sponsor: Shandong Suncadia Medicine Co., Ltd.
Conditions: Overweight; Obesity
Interventions: DRUG:HRS-7535 Tablets; DRUG:HRS-7535 Placebo Tablets
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Percentage change in body weight relative to the baseline [44th week after administration.]
Proportion of participants with a body weight reduction of ≥ 5% relative to the baseline [44th week after administration.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.